- Report
- March 2025
- 1048 Pages
Global
From €4563EUR$4,799USD£3,837GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,477GBP
- Report
- March 2025
- 200 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- March 2025
- 175 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- March 2025
- 144 Pages
Global
From €2851EUR$2,999USD£2,398GBP
- Report
- May 2024
- 134 Pages
Global
From €6179EUR$6,499USD£5,196GBP
- Clinical Trials
- November 2024
- 80 Pages
Global
From €1902EUR$2,000USD£1,599GBP
- Report
- November 2024
- 97 Pages
Global
From €7559EUR$7,950USD£6,356GBP
- Report
- October 2024
- 160 Pages
Global
From €7559EUR$7,950USD£6,356GBP
- Report
- April 2024
- 566 Pages
Global
From €7559EUR$7,950USD£6,356GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,199GBP
- Report
- August 2024
- 187 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- March 2023
- 300 Pages
Global
From €2396EUR$2,520USD£2,015GBP
€2662EUR$2,800USD£2,239GBP
- Report
- June 2020
- 753 Pages
Global
From €2824EUR$2,970USD£2,375GBP
€3138EUR$3,300USD£2,638GBP
- Report
- March 2024
- 174 Pages
Global
From €7131EUR$7,500USD£5,996GBP
- Report
- March 2024
- 134 Pages
Global
From €7559EUR$7,950USD£6,356GBP
- Report
- March 2024
- 257 Pages
Global
From €7131EUR$7,500USD£5,996GBP
- Report
- November 2023
- 224 Pages
Global
From €7131EUR$7,500USD£5,996GBP

Cyclophosphamide is a drug used to treat immune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, and vasculitis. It is a type of alkylating agent, which works by inhibiting the growth of certain cells in the body. It is usually administered intravenously or orally, and is often used in combination with other drugs. Cyclophosphamide is also used to treat certain types of cancer, such as lymphoma and leukemia.
Cyclophosphamide is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other drugs. It is generally well tolerated, with few side effects. However, it can cause serious side effects, such as bone marrow suppression, and should be used with caution.
Some of the companies in the Cyclophosphamide market include Pfizer, Novartis, Merck, and Bristol-Myers Squibb. Show Less Read more